Siste oppdatering :
07/07/2025
Forskerteamet - Quality Evaluation Team, Samsung Bioepis Co   pdf  
Japan
farmasøytiske laboratorier
Quality Evaluation Team, Samsung Bioepis Co
Incheon
Referanser   Referanser   (5)  
1
In‑Use Stability of SB12 (Eculizumab, Soliris Biosimilar) Diluted in Saline and Dextrose Infusion Solution after an Extended Storage Period.
Tak M, Jeong H, Yun J, Kim J, Kim S, Lee Y, Park S-J. (sujin8171.park@samsung.com)
Drugs R D - 2023 - ;23,4:363 - 375
2
Physicochemical and Biological Stability Assessment of SB11 (Ranibizumab Biosimilar) Under Ambient and In-Use Storage for Intravitreal Administration.
Kaiser P.K, Yun J, Kim S, Kim J, Park S.J. (sujin8171.park@samsung.com)
Ophtalmol Ther - 2023 - ; 12:985–998.
3
4
Extended Stability of Reconstituted and Diluted SB3 (Trastuzumab Biosimilar) Assessed by Physicochemical and Biological Properties
Yun J, Kim J, Chung J, Hwang S-J, Park S-J. (sujin8171.park@samsung.com)
Adv Ther - 2019 -
5
Evaluation of Physicochemical and Biological Stability of 36-Months-Aged SB5 (Adalimumab Biosimilar) for 4 Weeks at Room Temperature.
Park D, Yun J, Hwang S-J, Park SJ. (sujin8171.park@samsung.com)
Adv Ther - 2019 - 36:442–450

Lister   molekyler Studerte   (5)  
Immunosuppressiva Injeksjon Adalimumab
kreft narkotika Injeksjon Bevacizumab
Forskjellig Injeksjon Eculizumab
Forskjellig Injeksjon Ranibizumab
kreft narkotika Injeksjon Trastuzumab

  Mentions Légales
BESbswy